Business Context and Reporting Period
Kustom Entertainment, Inc. (KUST) filed a Form 8-K on January 12, 2026, reporting a material transaction that closed on January 8, 2026. The Company, through its wholly-owned subsidiary Digital Ally Healthcare, Inc., disposed of its ownership interest in Nobility Healthcare, LLC.
Key Financial Metrics and Transaction Details
- Transaction Type: Disposition of assets (sale of subsidiary units).
- Total Consideration: $1,450,000.
- Payment Structure:
- Cash at Closing: $100,000.
- Credits Applied: $209,501 (comprising $200,000 in prior advances and $9,501 in net working capital adjustments).
- Promissory Note: $1,140,499 issued by the Buyer.
- Asset Sold: 51,000 Units of Nobility Healthcare (representing 51% of the 100,000 total units issued).
- Buyer: Nobility LLC, an affiliate of the owner of the remaining 49% of Nobility Healthcare units.
Material Changes Versus Prior Period
This filing represents a significant change in the Company's asset base and revenue streams, as it divests its majority stake in Nobility Healthcare. The transaction effectively consolidates Nobility Healthcare under the control of the remaining 49% owner. The filing references unaudited pro forma financial statements (Exhibit 99.2) reflecting the impact of this sale on the balance sheet as of September 30, 2025, and operations for the nine months ended September 30, 2025, and the year ended December 31, 2024. Specific comparative revenue or profit figures for the prior period are not detailed in the text of this 8-K.
Guidance, Outlook, and Risks
- Management Commentary: The Company issued a press release on January 12, 2026, announcing the completion of the transaction. No specific forward-looking guidance or outlook was provided in the text of this filing.
- Risks and Contingencies: The Company retains a receivable in the form of a promissory note ($1,140,499), introducing credit risk associated with the Buyer's ability to repay. The filing notes customary representations and warranties were made, but no specific litigation or regulatory contingencies were disclosed.
- Unusual Items: The transaction involved the application of prior advances ($200,000) and working capital adjustments ($9,501) as credits against the purchase price.
Investor Verification Checklist
- Verify the terms and repayment schedule of the $1,140,499 promissory note issued by Nobility LLC.
- Review the unaudited pro forma financial statements (Exhibit 99.2) to assess the impact of the divestiture on the Company's consolidated balance sheet and liquidity.
- Confirm the status of the $200,000 in advances previously made to the Seller and how they were accounted for in the closing credits.
- Assess the strategic rationale for exiting the Nobility Healthcare venture and the Company's future focus areas.